1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, July 2016 (p7)

Biological Therapy Analysis & Statistics, July 2016 (p7)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

181-210 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • July 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy
Protokinetix Inc. (PKTX) - Financial and Strategic SWOT Analysis Review

Protokinetix Inc. (PKTX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • July 2016
  • by Global Data

Summary ProtoKinetix Inc. (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company’s develops anti-aging glycopeptides used to protect cell lines which ...

  • Industries : Biological Therapy
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • July 2016
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company provides elelyso, a plant cell-expressed ...

  • Industries : Biological Therapy
Alethia Biotherapeutics Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alethia Biotherapeutics Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Alethia Biotherapeutics Inc. (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products include AB-25E9 bone antiresorptive, ...

Antisense Therapeutics Limited (ANP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Antisense Therapeutics Limited (ANP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Antisense Therapeutics Limited (Antisense Therapeutics) is clinical staged biopharmaceutical company which focuses on the discovery, development and commercialization of second generation antisense ...

  • Industries : Therapy, Biological Therapy
Aeglea BioTherapeutics, Inc. (AGLE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aeglea BioTherapeutics, Inc. (AGLE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Aeglea BioTherapeutics, Inc. (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops engineered human enzymes and companion diagnostics ...

  • Countries : United States
U.S. Stem Cell, Inc. (USRM) - Medical Equipment - Deals and Alliances Profile

U.S. Stem Cell, Inc. (USRM) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary U.S. Stem cell, Inc., (formerly Bioheart, Inc.) is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs ...

  • Industries : Biological Therapy
  • Countries : United States
Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile

Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Northwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated ...

  • Industries : Cancer, Biological Therapy, Pathology
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Interleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict ...

  • Industries : General Medicine and Specialty Medicine
Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • September 2016
  • by Global Data

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy, Biological Therapy
U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review

U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • July 2016
  • by Global Data

U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...

  • Industries : Biological Therapy
  • Countries : United States
US Stem Cell Inc

US Stem Cell Inc

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for US Stem Cell Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : United States
Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
  • Countries : United States, World
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Northwest Biotherapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
  • Countries : United States
Eleven Biotherapeutics Inc

Eleven Biotherapeutics Inc

  • $ 99
  • Company report
  • August 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Eleven Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biological Therapy
  • Countries : United States
Asterias Biotherapeutics Inc

Asterias Biotherapeutics Inc

  • $ 99
  • Company report
  • August 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Asterias Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States, World
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 99
  • Company report
  • August 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
  • Countries : Japan
GEH/FedDev/CCRM – Toronto Centre for Advanced Therapeutic Cell Technologies – Ontario - Construction Project Profile

GEH/FedDev/CCRM – Toronto Centre for Advanced Therapeutic Cell Technologies – Ontario - Construction Project Profile

  • $ 75
  • Industry report
  • June 2016
  • by Timetric

Synopsis "GEH/FedDev/CCRM – Toronto Centre for Advanced Therapeutic Cell Technologies – Ontario - Construction Project Profile" contains information on the scope of the project including project overview ...

  • Industries : Biological Therapy, Construction
  • Countries : Canada
Global and Chinese Cell Culture Dashboard Industry, 2016 Market Research Report

Global and Chinese Cell Culture Dashboard Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • June 2016
  • by Prof Research

The 'Global and Chinese Cell Culture Dashboard Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Cell Culture Dashboard industry with a ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Global and Chinese Embryonic Stem Cell (hESC) Products Industry, 2016 Market Research Report

Global and Chinese Embryonic Stem Cell (hESC) Products Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • June 2016
  • by Prof Research

The 'Global and Chinese Embryonic Stem Cell (hESC) Products Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Embryonic Stem Cell (hESC) ...

  • Industries : Biological Therapy
  • Countries : World
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology, Cancer, Pharmaceutical
  • Countries : United States
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme ...

  • Industries : Cancer, Pathology
  • Countries : United States
Acute Lung Injury - Pipeline Review, H1 2016

Acute Lung Injury - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • June 2016
  • by Global Markets Direct

Acute Lung Injury - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H1 2016’, provides an overview of the Acute Lung Injury pipeline landscape. The ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Liver Cancer - Pipeline Review, H1 2016

Liver Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 ...

  • Industries : Cancer, Therapy, Pathology, Biotechnology, Oncology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical, Biological Therapy, Pathology, Therapy, Biotechnology, Cancer
  • Countries : United States
C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (C-C CKR-5 ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical
  • Countries : United States
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology
  • Countries : United States
Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Tumor Necrosis Factor Recepto ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology, Pathology
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.